Venous Thromboembolism
📧 Sign up to get email alerts when something new happens for Venous Thromboembolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS)
This clinical trial update describes the PREDICTORS study investigating predictors of recurrent venous thromboembolism in patients with a hi…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot
A pediatric clinical trial evaluating safety and effectiveness of Pradaxa pellets (dabigatran etexilate) for venous thromboembolism in child…
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT [Phase 4]
Phase 4 clinical trial evaluating individualized targeted prophylaxis for venous thromboembolism in patients undergoing total hip or total k…
-
EMA approval · 2025-08-28EMA Authorised: Rivaroxaban Accord (rivaroxaban) — Accord Healthcare S.L.U.
The EMA authorised Accord Healthcare's rivaroxaban product (Rivaroxaban Accord) for multiple indications including acute coronary syndrome, …
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: Heat Shock Protein 47 in Thrombosis
A University of Aarhus-sponsored clinical trial is evaluating Heat Shock Protein 47 in thrombosis, with ongoing recruitment for venous throm…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-13Clinical Trial Update: Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs [Phase 3]
Phase 3 trial evaluating apixaban for prevention of venous thromboembolism in patients with multiple myeloma treated with IMiDs has complete…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event [Phase 4]
Phase 4 clinical trial evaluating the role of statin therapy in venous dysfunction among patients with venous thromboembolism has completed.…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait
A completed clinical trial update from NHLBI evaluating biomarkers related to venous thrombosis in people with sickle cell disease and sickl…
-
CLINICAL_TRIALS other · 2025-07-31Clinical Trial Update: Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery [NA]
Clinical trial update for a study sponsored by the Medical University of South Carolina to improve utilization of extended venous thromboemb…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Medication Use Evaluation for Enoxaparin in Hospitalized COVID-19 Patients
A completed medication-use evaluation assessing enoxaparin for venous thromboembolism management in hospitalized COVID-19 patients.
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery [Phase 2]
A Phase 2 clinical trial update for SHR-2004 Injection aimed at preventing postoperative venous thromboembolism in patients undergoing ovari…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma [Phase 3]
A Phase 3 trial evaluating aspirin versus rivaroxaban for thromboprophylaxis in patients with multiple myeloma to prevent venous thromboembo…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Excretion of Rivaroxaban in Human Breast Milk [Phase 1]
Phase 1 clinical trial updating excretion of rivaroxaban into human breast milk in postpartum women; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants [Phase 2]
A Phase 2 trial assessed REGN9933 for preventing venous thromboembolism after knee replacement surgery; results have been posted.
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy [Phase 2, Phase 3]
A clinical trial update indicating recruitment for a Phase 2/3 study evaluating rivaroxaban to prevent venous thromboembolism in patients wi…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters [Phase 3]
Phase 3 trial evaluating primary thromboprophylaxis to prevent venous thromboembolism in cancer patients with central venous catheters. The …
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Abbott Vascular Medical Device Registry
Abbott Vascular's medical device registry study is currently recruiting, evaluating outcomes in patients with acute myocardial infarction an…
-
FDA label_change · 2025-07-02FDA Approved: WARFARIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Warfarin Sodium by Teva Pharmaceuticals USA, Inc., resulting in changes to the product labeling.…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Construction and External Validation of a Predictive Clinico-biological Score of the Risk of Venous Thrombosis in Women Under Combined Oral Contraceptives [NA]
Clinical trial update on developing and externally validating a predictive clinico-biological score for venous thromboembolism risk in women…
-
FDA approval · 2025-06-26FDA Approved: RIVAROXABAN — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories' generic rivaroxaban (RIVAROXABAN) under an Original Application, enabling a generic version of the anticoa…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support
Clinical trial update on using a new clinical decision support tool to exclude venous thromboembolism; sponsored by Diagnostica Stago R&D, t…
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT [Phase 1, Phase 2]
A randomized trial comparing apixaban to enoxaparin for venous thromboembolism prevention after microsurgical breast reconstruction has comp…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer [Phase 3]
Phase 3 trial results for apixaban in the treatment of venous thromboembolism in cancer patients have been posted after study completion.
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Supplemental Oxygen in Pulmonary Embolism (SO-PE) [EARLY_Phase 1]
A Phase 1 study from Massachusetts General Hospital evaluating supplemental oxygen therapy in pulmonary embolism is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study
Results from a UK matched-cohort study examine the risk of venous thromboembolism among people with systemic inflammatory disorders. The tri…